NEGRAM (1-ETHYL-7-METHYL-1,8-NAPHTHYRIDINE-4-ONE-3-CARBOXYLIC ACID): A NEW ANTIBACTERIAL AGENT FOR THE TREATMENT OF URINARY INFECTION. REPORT OF A TRIAL IN GENERAL PRACTICE.
D000293:Adolescent; D000900:Anti-Bacterial Agents; D035843:Biomedical Research; D002177:Candidiasis; D002264:Carboxylic Acids; D002648:Child; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D013293:Enterococcus faecalis; D004926:Escherichia coli; D058006:General Practice; D005853:Geriatrics; D007223:Infant; D007231:Infant, Newborn; D009287:Naphthyridines; D011512:Proteus Infections; D011552:Pseudomonas Infections; D013203:Staphylococcal Infections; D013290:Streptococcal Infections; D014116:Toxicology; D014552:Urinary Tract Infections
D000900:Anti-Bacterial Agents; D002264:Carboxylic Acids; D009287:Naphthyridines
ADOLESCENCE; CHILD; CLINICAL RESEARCH; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; GERIATRICS; INFANT; INFANT, NEWBORN; MONILIASIS; NAPHTHYRIDINES; PROTEUS INFECTIONS; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS FAECALIS; TOXICOLOGIC REPORT; URINARY TRACT INFECTIONS